Drug – bio-affecting and body treating compositions – Radionuclide or intended radionuclide containing; adjuvant... – Molecular bilayer structure
Patent
1981-08-12
1984-01-17
Naff, David M.
Drug, bio-affecting and body treating compositions
Radionuclide or intended radionuclide containing; adjuvant...
Molecular bilayer structure
424324, 564153, A61K 4904, A61K 31165
Patent
active
044263716
ABSTRACT:
Novel N-hydroxyalkylated dicarboxylic acid bis(3,5-dicarbamoyl-2,4,6-triiodoanilides) have Formula I ##STR1## wherein R.sup.1 is a lower, linear or branched mono- or polyhydroxyalkyl residue,
REFERENCES:
patent: 3701771 (1972-10-01), Almen et al.
patent: 4001323 (1977-01-01), Felder et al.
patent: 4021481 (1977-05-01), Almen et al.
patent: 4062934 (1977-12-01), Tilly et al.
patent: 4230845 (1980-10-01), Smith
patent: 4250113 (1981-02-01), Nordal et al.
patent: 4283381 (1981-08-01), Speck et al.
Pfeiffer Heinrich
Speck Ulrich
Naff David M.
Pepper Frederick W.
Schering Aktiengesellschaft
LandOfFree
Novel N-hydroxyalkylated dicarboxylic acid bis(3,5-dicarbamoyl-2 does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Novel N-hydroxyalkylated dicarboxylic acid bis(3,5-dicarbamoyl-2, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Novel N-hydroxyalkylated dicarboxylic acid bis(3,5-dicarbamoyl-2 will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-700328